Adoracion Gomez Quiroga - Publications

Affiliations: 
University of Madrid, Spain 

63 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Fabra D, Amariei G, Ruiz-Camino D, Matesanz AI, Rosal R, Quiroga AG, Horcajada P, Hidalgo T. Proving the Antimicrobial Therapeutic Activity on a New Copper-Thiosemicarbazone Complex. Molecular Pharmaceutics. 21: 1987-1997. PMID 38507593 DOI: 10.1021/acs.molpharmaceut.3c01235  0.301
2023 Herrero JM, Fabra D, Matesanz AI, Hernández C, Sánchez-Pérez I, Quiroga AG. Dithiobiureas Palladium(II) complexes' studies: From their synthesis to their biological action. Journal of Inorganic Biochemistry. 246: 112261. PMID 37271620 DOI: 10.1016/j.jinorgbio.2023.112261  0.385
2020 Matesanz AI, Caballero AB, Lorenzo C, Espargaró A, Sabaté R, Quiroga AG, Gamez P. Thiosemicarbazone Derivatives as Inhibitors of Amyloid-β Aggregation: Effect of Metal Coordination. Inorganic Chemistry. 59: 6978-6987. PMID 32369695 DOI: 10.1021/Acs.Inorgchem.0C00467  0.393
2019 Quiroga AG, Cama M, Pajuelo-Lozano N, Álvarez-Valdés A, Perez IS. New Findings in the Signaling Pathways of and Platinum Iodido Complexes' Interaction with DNA of Cancer Cells. Acs Omega. 4: 21855-21861. PMID 31891063 DOI: 10.1021/acsomega.9b02831  0.37
2019 Matesanz AI, Herrero JM, Faraco EJ, Cubo L, Quiroga AG. New Platinum(II) Triazole Thiosemicarbazone Complexes: Analysis of Their Reactivity and Potential Antitumoral Action. Chembiochem : a European Journal of Chemical Biology. PMID 31746118 DOI: 10.1002/Cbic.201900545  0.53
2019 Fuentes L, Quiroga AG, Organero JA, Matesanz AI. Exploring DNA binding ability of two novel α-N-heterocyclic thiosemicarbazone palladium(II) complexes. Journal of Inorganic Biochemistry. 203: 110875. PMID 31706223 DOI: 10.1016/J.Jinorgbio.2019.110875  0.444
2019 Cabrera S, Navas F, Matesanz AI, Maroto M, Riedel T, Dyson PJ, Quiroga AG. Versatile Route to trans-Platinum(II) Complexes via Manipulation of a Coordinated 3-(Pyridin-3-yl)propanoic Acid Ligand. Inorganic Chemistry. PMID 30978015 DOI: 10.1021/Acs.Inorgchem.9B00126  0.504
2019 Castro AC, Fliegl H, Cascella M, Helgaker T, Repisky M, Komorovsky S, Medrano MÁ, Quiroga AG, Swart M. Four-component relativistic P NMR calculations for trans-platinum(ii) complexes: importance of the solvent and dynamics in spectral simulations. Dalton Transactions (Cambridge, England : 2003). PMID 30916692 DOI: 10.1039/C9Dt00570F  0.368
2019 Alvarez-Valdes A, Matesanz AI, Perles J, Fernandes C, Correia JDG, Mendes F, Quiroga AG. Novel structures of platinum complexes bearing N‑bisphosphonates and study of their biological properties. Journal of Inorganic Biochemistry. 191: 112-118. PMID 30496946 DOI: 10.1016/J.Jinorgbio.2018.11.010  0.509
2018 Pajuelo-Lozano N, Bargiela-Iparraguirre J, Dominguez G, Quiroga AG, Perona R, Sanchez-Perez I. XPA, XPC, and XPD Modulate Sensitivity in Gastric Cisplatin Resistance Cancer Cells. Frontiers in Pharmacology. 9: 1197. PMID 30386247 DOI: 10.3389/Fphar.2018.01197  0.31
2018 Echeverri M, Alvarez-Valdés A, Navas F, Perles J, Sánchez-Pérez I, Quiroga AG. Using phosphine ligands with a biological role to modulate reactivity in novel platinum complexes. Royal Society Open Science. 5: 171340-171340. PMID 29515851 DOI: 10.1098/Rsos.171340  0.452
2018 Marzo T, Navas F, Cirri D, Merlino A, Ferraro G, Messori L, Quiroga AG. Reactions of a tetranuclear Pt-thiosemicarbazone complex with model proteins. Journal of Inorganic Biochemistry. 181: 11-17. PMID 29353085 DOI: 10.1016/J.Jinorgbio.2018.01.002  0.415
2018 Matesanz AI, Jimenez-Faraco E, Ruiz MC, Balsa LM, Navarro-Ranninger C, León IE, Quiroga AG. Mononuclear Pd(II) and Pt(II) complexes with an α-N-heterocyclic thiosemicarbazone: cytotoxicity, solution behaviour and interaction versus proven models from biological media Inorganic Chemistry Frontiers. 5: 73-83. DOI: 10.1039/C7Qi00446J  0.515
2017 Navas F, Mendes F, Santos I, Navarro-Ranninger C, Cabrera S, Quiroga AG. Enhanced Cytotoxicity and Reactivity of a Novel Platinum(IV) Family with DNA-Targeting Naphthalimide Ligands. Inorganic Chemistry. PMID 28488859 DOI: 10.1021/Acs.Inorgchem.7B00136  0.536
2017 Quental L, Raposinho P, Mendes F, Santos I, Navarro-Ranninger C, Alvarez-Valdes A, Huang H, Chao H, Rubbiani R, Gasser G, Quiroga AG, Paulo A. Combining imaging and anticancer properties with new heterobimetallic Pt(ii)/M(i) (M = Re, (99m)Tc) complexes. Dalton Transactions (Cambridge, England : 2003). PMID 28164201 DOI: 10.1039/C7Dt00043J  0.461
2017 Medrano MA, Morais M, Ferreira VFC, Correia JDG, Paulo A, Santos I, Navarro-Ranninger C, Valdes AA, Casini A, Mendes F, Quiroga AG. Nonconventionaltrans-Platinum Complexes Functionalized with RDG Peptides: Chemical and Cytototoxicity Studies European Journal of Inorganic Chemistry. 2017: 1835-1840. DOI: 10.1002/Ejic.201700072  0.472
2016 Marzo T, Bartoli G, Gabbiani C, Pescitelli G, Severi M, Pillozzi S, Michelucci E, Fiorini B, Arcangeli A, Quiroga AG, Messori L. Cisplatin and its dibromido analogue: a comparison of chemical and biological profiles. Biometals : An International Journal On the Role of Metal Ions in Biology, Biochemistry, and Medicine. 29: 535-42. PMID 27086032 DOI: 10.1007/S10534-016-9934-4  0.353
2015 Navas F, Perfahl S, Garino C, Salassa L, Novakova O, Navarro-Ranninger C, Bednarski PJ, Malina J, Quiroga AG. Increasing DNA reactivity and in vitro antitumor activity of trans diiodido Pt(II) complexes with UVA light. Journal of Inorganic Biochemistry. 153: 211-8. PMID 26296459 DOI: 10.1016/J.Jinorgbio.2015.07.008  0.52
2015 Marzo T, Pillozzi S, Hrabina O, Kasparkova J, Brabec V, Arcangeli A, Bartoli G, Severi M, Lunghi A, Totti F, Gabbiani C, Quiroga AG, Messori L. cis-Pt I2(NH3)2: a reappraisal. Dalton Transactions (Cambridge, England : 2003). 44: 14896-905. PMID 26226326 DOI: 10.1039/C5Dt01196E  0.444
2015 Medrano A, Dennis SM, Alvarez-Valdés A, Perles J, McGregor Mason T, Quiroga AG. Synthesis, cytotoxicity, DNA interaction and cell cycle studies of trans-diiodophosphine Pt(II) complexes. Dalton Transactions (Cambridge, England : 2003). 44: 3557-62. PMID 25310702 DOI: 10.1039/C4Dt02392G  0.572
2014 Herrera JM, Mendes F, Gama S, Santos I, Navarro Ranninger C, Cabrera S, Quiroga AG. Design and biological evaluation of new platinum(II) complexes bearing ligands with DNA-targeting ability. Inorganic Chemistry. 53: 12627-34. PMID 25402634 DOI: 10.1021/Ic502373N  0.536
2014 Messori L, Marzo T, Michelucci E, Russo Krauss I, Navarro-Ranninger C, Quiroga AG, Merlino A. Interactions between anticancer trans-platinum compounds and proteins: crystal structures and ESI-MS spectra of two protein adducts of trans-(dimethylamino)(methylamino)dichloridoplatinum(II). Inorganic Chemistry. 53: 7806-8. PMID 25025479 DOI: 10.1021/Ic5012583  0.41
2013 Messori L, Marzo T, Gabbiani C, Valdes AA, Quiroga AG, Merlino A. Peculiar features in the crystal structure of the adduct formed between cis-PtI2(NH3)2 and hen egg white lysozyme. Inorganic Chemistry. 52: 13827-9. PMID 24256441 DOI: 10.1021/Ic402611M  0.442
2013 Martín Santos C, Cabrera S, Ríos-Luci C, Padrón JM, López Solera I, Quiroga AG, Medrano MA, Navarro-Ranninger C, Alemán J. Novel clioquinol and its analogous platinum complexes: importance, role of the halogen substitution and the hydroxyl group of the ligand. Dalton Transactions (Cambridge, England : 2003). 42: 13343-8. PMID 23945635 DOI: 10.1039/C3Dt51720A  0.454
2013 Parro T, Medrano MA, Cubo L, Muñoz-Galván S, Carnero A, Navarro-Ranninger C, Quiroga AG. The second generation of iodido complexes: trans-[PtI2(amine)(amine')] bearing different aliphatic amines. Journal of Inorganic Biochemistry. 127: 182-7. PMID 23688840 DOI: 10.1016/J.Jinorgbio.2013.04.010  0.52
2013 Medrano MÁ, Álvarez-Valdés A, Perles J, Lloret-Fillol J, Muñoz-Galván S, Carnero A, Navarro-Ranninger C, Quiroga AG. Oxidation of anticancer Pt(II) complexes with monodentate phosphane ligands: towards stable but active Pt(IV) prodrugs. Chemical Communications (Cambridge, England). 49: 4806-8. PMID 23591566 DOI: 10.1039/C3Cc38416K  0.566
2012 Quiroga AG. Understanding trans platinum complexes as potential antitumor drugs beyond targeting DNA. Journal of Inorganic Biochemistry. 114: 106-112. PMID 22819649 DOI: 10.1016/J.Jinorgbio.2012.06.002  0.49
2012 Messori L, Cubo L, Gabbiani C, Álvarez-Valdés A, Michelucci E, Pieraccini G, Ríos-Luci C, León LG, Padrón JM, Navarro-Ranninger C, Casini A, Quiroga AG. Reactivity and biological properties of a series of cytotoxic PtI2(amine)2 complexes, either cis or trans configured. Inorganic Chemistry. 51: 1717-26. PMID 22225466 DOI: 10.1021/Ic202036C  0.552
2011 Cubo L, Hambley TW, Sanz Miguel PJ, Carnero A, Navarro-Ranninger C, Quiroga AG. The preparation and characterization of trans-platinum(IV) complexes with unusually high cytotoxicity. Dalton Transactions (Cambridge, England : 2003). 40: 344-7. PMID 20936210 DOI: 10.1039/C0Dt00565G  0.542
2011 Quiroga AG, Ramos-Lima FJ, Alvarez-Valdés A, Font-Bardía M, Bergamo A, Sava G, Navarro-Ranninger C. Synthesis, characterization and tumor cell growth inhibition of new trans platinum complexes with phosphane derivatives Polyhedron. 30: 1646-1650. DOI: 10.1016/J.Poly.2011.03.034  0.505
2010 Messori L, Casini A, Gabbiani C, Michelucci E, Cubo L, Ríos-Luci C, Padrón JM, Navarro-Ranninger C, Quiroga AG. Cytotoxic Profile and Peculiar Reactivity with Biomolecules of a Novel "Rule-Breaker" Iodidoplatinum(II) Complex. Acs Medicinal Chemistry Letters. 1: 381-5. PMID 24900222 DOI: 10.1021/Ml100081E  0.514
2010 Sanchez-Cano C, Huxley M, Ducani C, Hamad AE, Browning MJ, Navarro-Ranninger C, Quiroga AG, Rodger A, Hannon MJ. Conjugation of testosterone modifies the interaction of mono-functional cationic platinum(II) complexes with DNA, causing significant alterations to the DNA helix. Dalton Transactions (Cambridge, England : 2003). 39: 11365-74. PMID 21031219 DOI: 10.1039/C0Dt00839G  0.643
2010 Huxley M, Sanchez-Cano C, Browning MJ, Navarro-Ranninger C, Quiroga AG, Rodger A, Hannon MJ. An androgenic steroid delivery vector that imparts activity to a non-conventional platinum(II) metallo-drug. Dalton Transactions (Cambridge, England : 2003). 39: 11353-64. PMID 21031218 DOI: 10.1039/C0Dt00838A  0.633
2010 Alemán J, del Solar V, Cubo L, Quiroga AG, Navarro Ranninger C. New reactions of anticancer-platinum complexes and their intriguing behaviour under various experimental conditions. Dalton Transactions (Cambridge, England : 2003). 39: 10601-7. PMID 20922260 DOI: 10.1039/C0Dt00506A  0.374
2010 Cubo L, Groessl M, Dyson PJ, Quiroga AG, Navarro-Ranninger C, Casini A. Proteins as possible targets for cytotoxic trans-platinum(II) complexes with aliphatic amine ligands: Further exceptions to the DNA paradigm. Chemmedchem. 5: 1335-43. PMID 20564276 DOI: 10.1002/Cmdc.201000104  0.525
2010 Cubo L, Pizarro AM, Quiroga AG, Salassa L, Navarro-Ranninger C, Sadler PJ. Photoactivation of trans diamine platinum complexes in aqueous solution and effect on reactivity towards nucleotides. Journal of Inorganic Biochemistry. 104: 909-18. PMID 20546905 DOI: 10.1016/J.Jinorgbio.2010.04.009  0.504
2010 Ramos-Lima FJ, Moneo V, Quiroga AG, Carnero A, Navarro-Ranninger C. The role of p53 in the cellular toxicity by active trans-platinum complexes containing isopropylamine and hydroxymethylpyridine. European Journal of Medicinal Chemistry. 45: 134-41. PMID 19853978 DOI: 10.1016/J.Ejmech.2009.09.035  0.517
2009 Cubo L, Casini A, Gabbiani C, Mastrobuoni G, Messori L, Jiménez-Barbero J, Navarro-Ranninger C, Quiroga AG. Solution behaviour and biomolecular interactions of two cytotoxic trans-platinum(II) complexes bearing aliphatic amine ligands Chemistry (Weinheim An Der Bergstrasse, Germany). 15: 9139-9146. PMID 19655350 DOI: 10.1002/Chem.200901090  0.488
2009 Rodríguez-García ME, Quiroga AG, Castro J, Ortiz A, Aller P, Mata F. Inhibition of p38-MAPK potentiates cisplatin-induced apoptosis via GSH depletion and increases intracellular drug accumulation in growth-arrested kidney tubular epithelial cells. Toxicological Sciences : An Official Journal of the Society of Toxicology. 111: 413-23. PMID 19578154 DOI: 10.1093/Toxsci/Kfp145  0.305
2009 Cubo L, Quiroga AG, Zhang J, Thomas DS, Carnero A, Navarro-Ranninger C, Berners-Price SJ. Influence of amine ligands on the aquation and cytotoxicity of trans-diamine platinum(II) anticancer complexes. Dalton Transactions (Cambridge, England : 2003). 3457-66. PMID 19381408 DOI: 10.1039/B819301K  0.421
2009 Cubo L, Thomas DS, Zhang J, Quiroga AG, Navarro-Ranninger C, Berners-Price SJ. [1H,15N] NMR studies of the aquation of cis-diamine platinum(II) complexes Inorganica Chimica Acta. 362: 1022-1026. DOI: 10.1016/J.Ica.2008.03.117  0.357
2008 Medina RM, Rodríguez J, Quiroga AG, Ramos-Lima FJ, Moneo V, Carnero A, Navarro-Ranninger C, Macazaga MJ. Influence of (hydroxymethyl)pyridine and pyridine-carboxylic acids, in trans-position to the isopropylamine and amine ligands, on the cytotoxicity of platinum complexes. Chemistry & Biodiversity. 5: 2090-100. PMID 18972499 DOI: 10.1002/Cbdv.200890190  0.521
2008 Quiroga AG, Cubo L, Miguel PJS, Moneo V, Carnero A, Navarro‐Ranninger C. Isolation of an Intermediate in the Platination of p-Nitroacetophenone 4-Methylthiosemicarbazone: Potential Application as an Antitumor Drug (Eur. J. Inorg. Chem. 8/2008) European Journal of Inorganic Chemistry. 2008: 1171-1171. DOI: 10.1002/Ejic.200890017  0.326
2008 Macazaga MJ, Rodríguez J, Quiroga AG, Peregina S, Carnero A, Navarro-Ranninger C, Medina RM. Platinum(IV) Complexes of 3‐ and 4‐Picolinic Acids Containing Ammine or Isopropylamine Ligands – Synthesis, Characteri­zation, X‐ray Structures, and Evaluation of Their Cytotoxic Activity against Cancer Cell Lines European Journal of Inorganic Chemistry. 2008: 4762-4769. DOI: 10.1002/Ejic.200800591  0.472
2008 Quiroga AG, Cubo L, Miguel PJS, Moneo V, Carnero A, Navarro-Ranninger C. Isolation of an Intermediate in the Platination of p-Nitroacetophenone 4-Methylthiosemicarbazone: Potential Application as an Antitumor Drug European Journal of Inorganic Chemistry. 2008: 1183-1187. DOI: 10.1002/Ejic.200800003  0.427
2007 Ramos-Lima FJ, Quiroga AG, García-Serrelde B, Blanco F, Carnero A, Navarro-Ranninger C. New trans-platinum drugs with phosphines and amines as carrier ligands induce apoptosis in tumor cells resistant to cisplatin. Journal of Medicinal Chemistry. 50: 2194-9. PMID 17407274 DOI: 10.1021/Jm061219C  0.468
2007 Quiroga AG, Cubo L, de Blas E, Aller P, Navarro-Ranninger C. Trans platinum complexes design: one novel water soluble oxime derivative that contains aliphatic amines in trans configuration. Journal of Inorganic Biochemistry. 101: 104-10. PMID 17049609 DOI: 10.1016/J.Jinorgbio.2006.08.012  0.498
2006 Ramos-Lima FJ, Vrána O, Quiroga AG, Navarro-Ranninger C, Halámiková A, Rybnícková H, Hejmalová L, Brabec V. Structural characterization, DNA interactions, and cytotoxicity of new transplatin analogues containing one aliphatic and one planar heterocyclic amine ligand. Journal of Medicinal Chemistry. 49: 2640-51. PMID 16610807 DOI: 10.1021/Jm0602514  0.478
2006 Quiroga AG, Pérez JM, Alonso C, Navarro-Ranninger C, Farrell N. Novel transplatinum(II) complexes with [N2O2] donor sets. Cellular pharmacology and apoptosis induction in Pam 212-ras cells. Journal of Medicinal Chemistry. 49: 224-31. PMID 16392807 DOI: 10.1021/Jm050804V  0.375
2005 Quintal SM, Qu Y, Quiroga AG, Moniodis J, Nogueira HI, Farrell N. Pyridine-carboxylate complexes of platinum. Effect of N,O-chelate formation on model bifunctional DNA-DNA and DNA-protein interactions. Inorganic Chemistry. 44: 5247-53. PMID 16022522 DOI: 10.1021/Ic050062W  0.396
2004 Navarro-Ranninger C, Ramos-Lima FJ, Vrana O, Novakova O, Quiroga AG, Brabec V. 553 Activation of trans geometry in bifunctional mononuclear platinum complexes by combining aliphatic and aromatic amines. Mechanistic studies on antitumor action Ejc Supplements. 2: 168-169. DOI: 10.1016/S1359-6349(04)80561-5  0.497
2004 Quiroga AG, Ranninger CN. Contribution to the SAR field of metallated and coordination complexes: Studies of the palladium and platinum derivatives with selected thiosemicarbazones as antitumoral drugs Coordination Chemistry Reviews. 248: 119-133. DOI: 10.1016/J.Cct.2003.11.004  0.573
2003 Ramos-Lima FJ, Quiroga AG, Pérez JM, Navarro-Ranninger C. Preparation, characterization and cytotoxic activity of new compounds trans-[PtCl2NH3(3-(hydroxymethyl)-pyridine)] and trans-[PtCl2NH3(4-(hydroxymethyl)-pyridine)] Polyhedron. 22: 3379-3381. DOI: 10.1016/J.Poly.2003.08.011  0.488
2003 Ramos‐Lima FJ, Quiroga AG, Pérez JM, Font‐Bardía M, Solans X, Navarro‐Ranninger C. Synthesis and Characterization of New Transplatinum Complexes Containing Phosphane Groups − Cytotoxic Studies in Cisplatin-Resistant Cells European Journal of Inorganic Chemistry. 2003: 1591-1598. DOI: 10.1002/Ejic.200390209  0.489
2002 Braña MF, Casarrubios L, Domínguez G, Fernández C, Pérez JM, Quiroga AG, Navarro-Ranninger C, de Pascual-Teresa B. Synthesis, cytotoxic activities and proposed mode of binding of a series of bis([(9-oxo-9,10-dihydroacridine-4-carbonyl)amino]alkyl) alkylamines. European Journal of Medicinal Chemistry. 37: 301-13. PMID 11960665 DOI: 10.1016/S0223-5234(02)01348-X  0.387
2001 Pérez JM, Montero EI, Quiroga AG, Fuertes MA, Alonso C, Navarro-Ranninger C. Cellular Uptake, DNA Binding and Apoptosis Induction of Cytotoxic Trans-[PtCl(2)(N,N-dimethylamine)(Isopropylamine)] in A2780cisR Ovarian Tumor Cells. Metal-Based Drugs. 8: 29-37. PMID 18475973 DOI: 10.1155/Mbd.2001.29  0.375
1999 Quiroga AG, Pérez JM, Montero EI, West DX, Alonso C, Navarro-Ranninger C. Synthesis and characterization of Pd(II) and Pt(II) complexes of p-isopropylbenzaldehyde N-protected thiosemicarbazones. Cytotoxic activity against ras-transformed cells. Journal of Inorganic Biochemistry. 75: 293-301. PMID 10499292 DOI: 10.1016/S0162-0134(99)00102-6  0.418
1999 Pérez JM, Quiroga AG, Montero EI, Alonso C, Navarro-Ranninger C. A cycloplatinated compound of p-isopropylbenzaldehyde thiosemicarbazone and its chloro-bridged derivative induce apoptosis in cis-DDP resistant cells which overexpress the H-ras oncogene. Journal of Inorganic Biochemistry. 73: 235-243. PMID 10376347 DOI: 10.1016/S0162-0134(99)00021-5  0.43
1999 Perez JM, Camazón M, Alvarez-Valdes A, Quiroga AG, Kelland LR, Alonso C, Navarro-Ranninger MC. Synthesis, characterization and DNA modification induced by a novel Pt(IV)-bis(monoglutarate) complex which induces apoptosis in glioma cells. Chemico-Biological Interactions. 117: 99-115. PMID 10190571 DOI: 10.1016/S0009-2797(98)00100-8  0.542
1998 Quiroga AG, Pérez JM, Montero EI, Masaguer JR, Alonso C, Navarro-Ranninger C. Palladated and platinated complexes derived from phenylacetaldehyde thiosemicarbazone with cytotoxic activity in cis- DDP resistant tumor cells. Formation of DNA interstrand cross-links by these complexes Journal of Inorganic Biochemistry. 70: 117-123. PMID 9666571 DOI: 10.1016/S0162-0134(98)10007-7  0.473
1998 Quiroga AG, Pérez JM, López-Solera I, Montero EI, Masaguer JR, Alonso C, Navarro-Ranninger C. Binuclear chloro-bridged palladated and platinated complexes derived from p-isopropylbenzaldehyde thiosemicarbazone with cytotoxicity against cisplatin resistant tumor cell lines Journal of Inorganic Biochemistry. 69: 275-281. PMID 9654751 DOI: 10.1016/S0162-0134(98)00003-8  0.477
1998 Quiroga AG, Pérez JM, López-Solera I, Masaguer JR, Luque A, Román P, Edwards A, Alonso C, Navarro-Ranninger C. Novel tetranuclear orthometalated complexes of Pd(II) and Pt(II) derived from p-isopropylbenzaldehyde thiosemicarbazone with cytotoxic activity in cis-DDP resistant tumor cell lines. Interaction of these complexes with DNA. Journal of Medicinal Chemistry. 41: 1399-1408. PMID 9554873 DOI: 10.1021/Jm970520D  0.453
1998 Quiroga AG, Pérez JM, Alonso C, Navarro‐Ranninger C. DNA binding and in vitro antileukemic activity of dimeric and tetrameric platinated complexes derived from p-isopropylbenzaldehyde thiosemicarbazone Applied Organometallic Chemistry. 12: 809-813. DOI: 10.1002/(Sici)1099-0739(199812)12:12<809::Aid-Aoc754>3.0.Co;2-X  0.513
Show low-probability matches.